Which of the following interventions is not recommended for a pediatric patient with supraventricular tachycardia (SVT)?

Digoxin is a medication commonly used to treat heart failure and certain heart rhythm disorders. However, it has a narrow therapeutic window, and digoxin toxicity can occur if the drug accumulates in the body to excessive levels. One of the hallmark signs of digoxin toxicity is severe bradycardia, which means an abnormally slow heart rate. Bradycardia can result from the effects of digoxin on the electrical conduction system of the heart, leading to an irregular or slowed heartbeat.

While other symptoms can occur in digoxin toxicity, such as gastrointestinal symptoms (like nausea and vomiting), neurological symptoms (like confusion and visual disturbances), and even respiratory distress in severe cases, extreme bradycardia is a key and often life-threatening sign that requires immediate medical attention.

Constipation (A) and headache (C) can also occur as side effects of digoxin but are less specific to digoxin toxicity and may not be considered cardinal manifestations.

Respiratory distress (B) may occur if the bradycardia leads to inadequate cardiac output, causing pulmonary congestion, but it is not a primary or cardinal symptom of digoxin toxicity. Extreme bradycardia is typically the more immediate and prominent concern.

The congenital heart diseases that often require multiple surgeries to correct are:

A.Tetralogy of Fallot usually requires staged surgical repairs, with multiple surgeries performed over time to address the various components of the defect.

B.Hypoplastic Left Heart Syndrome typically requires a series of staged surgeries, including the Norwood procedure, Glenn procedure, and Fontan procedure, to manage the condition.

E.While some cases can be corrected with a single surgery or catheter-based intervention, re-narrowing (re-coarctation) is common, especially in infants. This may necessitate repeat surgeries or balloon angioplasty later in life.